Gerwin Heller

CDK6 as a key regulator of hematopoietic and leukemic stem cell activation

Ruth Scheicher, Andrea Hoelbl‐Kovacic, Florian Bellutti et al. · Blood · 2014 · 279 citations · Full text

Life Sciences, Cell Biology, Hematology +14

Genome-Wide Transcriptional Response to 5-Aza-2′-Deoxycytidine and Trichostatin A in Multiple Myeloma Cells

Gerwin Heller, Wolfgang M. Schmidt, Barbara Ziegler et al. · Cancer Research · 2008 · 173 citations · Full text

Medicine, Cancer Biology, Oncology +17

Genome-Wide miRNA Expression Profiling Identifies <i>miR</i> - <i>9</i> - <i>3</i> and <i>miR</i> - <i>193a</i> as Targets for DNA Methylation in Non–Small Cell Lung Cancers

Gerwin Heller, Marlene Weinzierl, Christian Noll et al. · Clinical Cancer Research · 2012 · 160 citations · Full text

Life Sciences, Molecular Biology, Oncology +16

Aggressive B-cell lymphomas in patients with myelofibrosis receiving JAK1/2 inhibitor therapy

Edit Porpaczy, Sabrina Tripolt, Andrea Hoelbl‐Kovacic et al. · Blood · 2018 · 154 citations · Full text

Medicine, Hematology, Immunology +14

STAT5 Is a Key Regulator in NK Cells and Acts as a Molecular Switch from Tumor Surveillance to Tumor Promotion

Dagmar Gotthardt, Eva Maria Putz, Eva Grundschober et al. · Cancer Discovery · 2016 · 150 citations

Life Sciences, Immunology, Oncology +17